Rating History for Antibe Therapeutics (ATBPF) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/15/2020 | Sally Yanchus | New Coverage | Buy (N/A) |
2.06 (N/A) |
0.28 (0.22) |
-21.43% | Details |
